CODX Key Statistics, Chart & Performance
The current stock price of CODX is 2.36 USD. In the past month the price decreased by -76.96%. In the past year, price decreased by -90.1%.
CODX Technical Analysis
CODX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CODX. While CODX has a great health rating, there are worries on its profitability.
CODX Financial Highlights
Over the last trailing twelve months CODX reported a non-GAAP Earnings per Share(EPS) of -19.26. The EPS decreased by -1416.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -71.93% | ||
| ROE | -80.8% | ||
| Debt/Equity | 0 |
CODX Forecast & Estimates
8 analysts have analysed CODX and the average price target is 38.25 USD. This implies a price increase of 1520.76% is expected in the next year compared to the current price of 2.36.
For the next year, analysts expect an EPS growth of -1795.58% and a revenue growth -88.3% for CODX
CODX Ownership
CODX Latest News, Press Relases and Analysis
About CODX
Company Profile
Co-Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Salt Lake City, Utah and currently employs 132 full-time employees. The company went IPO on 2017-07-12. Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Company Info
CO-DIAGNOSTICS INC
2401 S. Foothill Dr. Suite D
Salt Lake City UTAH 84109 US
CEO: Dwight Egan
Employees: 132
Phone: 18014381036
CO-DIAGNOSTICS INC / CODX FAQ
What does CO-DIAGNOSTICS INC do?
Co-Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Salt Lake City, Utah and currently employs 132 full-time employees. The company went IPO on 2017-07-12. Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
What is the stock price of CO-DIAGNOSTICS INC today?
The current stock price of CODX is 2.36 USD. The price decreased by -60.54% in the last trading session.
Does CODX stock pay dividends?
CODX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CODX stock?
CODX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the market capitalization of CODX stock?
CO-DIAGNOSTICS INC (CODX) has a market capitalization of 143.70M USD. This makes CODX a Micro Cap stock.
What is the next earnings date for CODX stock?
CO-DIAGNOSTICS INC (CODX) will report earnings on 2026-03-25, after the market close.